Heterogeneity in signaling pathway activity within primary breast cancer and between primary and metastases.

589Background: Treatment with targeted drugs aims to block tumor driving signaling pathway(s). Drug choice is often based on a single preoperative primary breast cancer biopsy. It is important that...